NYSEMKT: ATNM
Actinium Pharmaceuticals Inc Stock Ownership - Who owns Actinium Pharmaceuticals?

Insider buying vs selling

Have Actinium Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ATNM insiders and whales buy or sell their stock.

ATNM Shareholders

What type of owners hold Actinium Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Diane S. Button64.11%20,000,000$31.00MInsider
Sloan Kettering Cancer Center Memorial33.38%10,411,948$16.14MInsider
Blackrock Inc6.24%1,946,946$3.02MInstitution
Vanguard Group Inc5.04%1,571,764$2.44MInstitution
Geode Capital Management LLC2.28%711,801$1.10MInstitution
State Street Corp2.07%645,215$1.00MInstitution
Acadian Asset Management LLC1.62%504,038$781.26kInstitution
Ubs Group Ag1.27%396,136$614.01kInstitution
Sandesh Seth0.98%305,381$473.34kInsider
Los Angeles Capital Management LLC0.75%233,247$361.53kInstitution

1 of 3

ATNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATNM20.92%79.08%
GRCE29.10%50.93%
OSTX1.39%23.50%Net SellingNet Selling
RNXT27.55%11.41%Net BuyingNet Buying
NRSN0.84%0.00%

Actinium Pharmaceuticals Stock Ownership FAQ

Who owns Actinium Pharmaceuticals?

Actinium Pharmaceuticals (NYSEMKT: ATNM) is owned by 26.28% institutional shareholders, 99.32% Actinium Pharmaceuticals insiders, and 0.00% retail investors. Diane S. Button is the largest individual Actinium Pharmaceuticals shareholder, owning 20.00M shares representing 64.11% of the company. Diane S. Button's Actinium Pharmaceuticals shares are currently valued at $30.40M.

If you're new to stock investing, here's how to buy Actinium Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.